| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Is cocaine desire reduced by N-acetylcysteine?
|
Am J Psychiatry
|
2007
|
2.08
|
|
2
|
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review.
|
Addict Biol
|
2012
|
1.63
|
|
3
|
Gabapentin combined with naltrexone for the treatment of alcohol dependence.
|
Am J Psychiatry
|
2011
|
1.63
|
|
4
|
Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals.
|
Am J Addict
|
2006
|
1.39
|
|
5
|
Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers.
|
Addict Biol
|
2011
|
1.30
|
|
6
|
Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
|
J Clin Psychopharmacol
|
2005
|
1.21
|
|
7
|
The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision.
|
J ECT
|
2004
|
1.19
|
|
8
|
Prolonged exposure therapy for combat-related posttraumatic stress disorder: an examination of treatment effectiveness for veterans of the wars in Afghanistan and Iraq.
|
J Anxiety Disord
|
2010
|
1.10
|
|
9
|
Telehealth service delivery for persons with alcoholism.
|
J Telemed Telecare
|
2005
|
1.03
|
|
10
|
Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
|
Neuropsychopharmacology
|
2012
|
1.03
|
|
11
|
Safety and efficacy of GABAergic medications for treating alcoholism.
|
Alcohol Clin Exp Res
|
2005
|
1.01
|
|
12
|
Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.
|
Alcohol Clin Exp Res
|
2008
|
0.98
|
|
13
|
Increased fasting plasma ghrelin levels during alcohol abstinence.
|
Alcohol Alcohol
|
2004
|
0.97
|
|
14
|
Stability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach.
|
Neuroimage
|
2011
|
0.97
|
|
15
|
Brain activation to cocaine cues and motivation/treatment status.
|
Addict Biol
|
2012
|
0.96
|
|
16
|
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
|
Alcohol Clin Exp Res
|
2012
|
0.95
|
|
17
|
Novel anticonvulsants in the treatment of alcoholism.
|
Expert Opin Investig Drugs
|
2005
|
0.94
|
|
18
|
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
|
J Clin Psychopharmacol
|
2009
|
0.93
|
|
19
|
Health service utilization before and after evidence-based treatment for PTSD.
|
Psychol Serv
|
2012
|
0.90
|
|
20
|
Prospective associations between brain activation to cocaine and no-go cues and cocaine relapse.
|
Drug Alcohol Depend
|
2013
|
0.89
|
|
21
|
Effects of naltrexone on the ethanol-induced changes in the rat central dopaminergic system.
|
Alcohol Alcohol
|
2005
|
0.89
|
|
22
|
The use of divalproex in alcohol relapse prevention: a pilot study.
|
Drug Alcohol Depend
|
2002
|
0.86
|
|
23
|
A pilot trial of neuropsychological evaluations conducted via telemedicine in the Veterans Health Administration.
|
Telemed J E Health
|
2012
|
0.85
|
|
24
|
Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
|
Psychopharmacology (Berl)
|
2014
|
0.85
|
|
25
|
Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence.
|
Exp Clin Psychopharmacol
|
2012
|
0.83
|
|
26
|
Prolonged exposure therapy for combat-related posttraumatic stress disorder: comparing outcomes for veterans of different wars.
|
Psychol Serv
|
2012
|
0.83
|
|
27
|
The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification.
|
Am J Addict
|
2002
|
0.83
|
|
28
|
Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient.
|
Am J Psychiatry
|
2007
|
0.83
|
|
29
|
Pregabalin is effective against behavioral and electrographic seizures during alcohol withdrawal.
|
Alcohol Alcohol
|
2006
|
0.82
|
|
30
|
Functional neuroanatomy of subcomponent cognitive processes involved in verbal working memory.
|
Int J Neurosci
|
2005
|
0.82
|
|
31
|
The relationship between years of cocaine use and brain activation to cocaine and response inhibition cues.
|
Addiction
|
2014
|
0.81
|
|
32
|
Combat posttraumatic stress disorder, substance use disorders, and traumatic brain injury.
|
J Addict Med
|
2009
|
0.80
|
|
33
|
Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics.
|
Psychopharmacology (Berl)
|
2013
|
0.78
|
|
34
|
Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.
|
Drug Alcohol Depend
|
2013
|
0.78
|
|
35
|
Computer simulation games as an adjunct for treatment in male veterans with alcohol use disorder.
|
J Subst Abuse Treat
|
2012
|
0.78
|
|
36
|
Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
|
Alcohol Clin Exp Res
|
2011
|
0.78
|
|
37
|
A severe case of clonidine dependence and withdrawal.
|
J Psychiatr Pract
|
2003
|
0.78
|
|
38
|
Health service use among persons with comorbid bipolar and substance use disorders.
|
Psychiatr Serv
|
2005
|
0.77
|
|
39
|
Risk factors for delirium tremens: a retrospective chart review.
|
Am J Addict
|
2006
|
0.77
|
|
40
|
Complexity changes of the EEG induced by alcohol cue exposure in alcoholics and social drinkers.
|
Alcohol Clin Exp Res
|
2003
|
0.76
|
|
41
|
Acamprosate: a new tool in the battle against alcohol dependence.
|
Neuropsychiatr Dis Treat
|
2006
|
0.76
|
|
42
|
Impact of lifetime alcohol quit attempts and medicated detoxifications on time to relapse during an index alcohol detoxification.
|
J Addict Med
|
2007
|
0.76
|
|
43
|
Beliefs as a predictor of relapse in alcohol-dependent Turkish men.
|
J Stud Alcohol
|
2005
|
0.75
|
|
44
|
Suicide-specific Safety in the Inpatient Psychiatric Unit.
|
Issues Ment Health Nurs
|
2015
|
0.75
|
|
45
|
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
|
Neuropsychopharmacology
|
2017
|
0.75
|